首页 | 本学科首页   官方微博 | 高级检索  
     


DLJ14, a novel chemo‐sensitization agent,enhances therapeutic effects of adriamycin against MCF‐7/A cells both in vitro and in vivo
Authors:Peng Zhang  Bei‐Bei Zheng  Hong‐Yuan Wang  Jin‐Hua Chen  Xin‐Yong Liu  Xiu‐Li Guo
Affiliation:1. Department of Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, , Jinan, China;2. Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, , Jinan, China
Abstract:
Keywords:Adr‐resistant human breast cancer cell (MCF‐7/A cell)  (E)‐2‐(2,4‐dimethoxystyryl)‐3,5,6‐trimethylpyrazine (DLJ14)  glutathione S‐transferase π   (GSTπ  )  multiple drug resistance  tumour xenograft
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号